Influence of age and K, Mg aspartate (Cardilan) on murine haemopoiesis

P Fedorocko1, N O Macková, Z Sándorcínová

  • 1Department of Cellular and Molecular Biology, Faculty of Sciences, P. J. Safárik University, Moyzesova 11, 04167, Kosice, Slovak Republic. fedvox@kosice.upjs.sk

Insights

Potassium and magnesium aspartate (Cardilan) supplementation positively impacts aging mice

Area of Science:

  • Hematology
  • Gerontology
  • Nutritional Science

Background:

  • Aging impacts hematopoietic stem cell function and peripheral blood cell counts.
  • The effects of mineral aspartate supplementation on aging hematopoiesis are not well understood.

Purpose of the Study:

  • To investigate the impact of aging on hematopoiesis in ICR mice.
  • To evaluate the effects of short-term and long-term Cardilan (K and Mg salts of aspartic acid) intake on hematopoietic parameters in aging mice.

Main Methods:

  • Assessed bone marrow cellularity, colony-forming cells (GM-CFC), spleen colony-forming units (CFU-S), and erythroid burst-forming units (BFU-E) in aging mice.
  • Administered Cardilan via short-term and long-term drinking protocols to different age groups of mice.
  • Monitored peripheral blood cell counts, including leukocytes and reticulocytes.

Main Results:

  • Aging increased bone marrow CFU-S and BFU-E, while decreasing peripheral leukocytes.
  • Short-term Cardilan intake boosted CFU-S, BFU-E, and reticulocytes in younger aging mice and increased spleen weight/cellularity and peripheral cells in older mice.
  • Long-term Cardilan intake elevated spleen GM-CFC in younger aging mice and reticulocytes in older mice.

Conclusions:

  • K and Mg salts of aspartic acid demonstrate a significant influence on erythropoietic activity.
  • Cardilan supplementation may offer benefits for hematopoietic function during the aging process.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...